A Unique DNA Binding Domain Converts T-Cell Factors into Strong Wnt Effectors

REFERENCES

• Ahn, J., and C. Prives. 2001. The C-terminus of p53: the more you learn the less you know. Nat. Struct. Biol. 8:730–732.
   PubMedGoogle Scholar
• Arce, L., N. N. Yokoyama, and M. L. Waterman. 2006. Diversity of LEF/TCF action in development and disease. Oncogene 25:7492–7504.
   PubMed Web of Science ®Google Scholar
• Atcha, F. A., J. E. Munguia, T. W. Li, K. Hovanes, and M. L. Waterman. 2003. A new beta-catenin dependent activation domain in T cell factor. J. Biol. Chem. 278:16169–16175.
   PubMedGoogle Scholar
• Ayed, A., F. A. Mulder, G. S. Yi, Y. Lu, L. E. Kay, and C. H. Arrowsmith. 2001. Latent and active p53 are identical in conformation. Nat. Struct. Biol. 8:756–760.
   PubMedGoogle Scholar
• Batlle, E., J. T. Henderson, H. Beghtel, M. M. van den Born, E. Sancho, G. Huls, J. Meeldijk, J. Robertson, M. van de Wetering, T. Pawson, and H. Clevers. 2002. β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB. Cell 111:251–263.
   PubMed Web of Science ®Google Scholar
• Béland, M., N. Pilon, M. Houle, K. Oh, J. R. Sylvestre, P. Prinos, and D. Lohnes. 2004. Cdx1 autoregulation is governed by a novel Cdx1-LEF1 transcription complex. Mol. Cell. Biol. 24:5028–5038.
   PubMed Web of Science ®Google Scholar
• Boeckle, S., H. Pfister, and G. Steger. 2002. A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2. Virology 293:103–117.
   PubMed Web of Science ®Google Scholar
• Connor, F., P. D. Cary, C. M. Read, N. S. Preston, P. C. Driscoll, P. Denny, C. Crane-Robinson, and A. Ashworth. 1994. DNA binding and bending properties of the post-meiotically expressed Sry-related protein Sox-5. Nucleic Acids Res. 22:3339–3346.
   PubMedGoogle Scholar
• Crawford, H. C., B. Fingleton, M. D. Gustavson, N. Kurpios, R. A. Wagenaar, J. A. Hassell, and L. M. Matrisian. 2001. The PEA3 subfamily of Ets transcription factors synergizes with β-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol. Cell. Biol. 21:1370–1383.
   PubMed Web of Science ®Google Scholar
• Daniels, D. L., and W. I. Weis. 2005. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 12:364–371.
   PubMed Web of Science ®Google Scholar
• El-Tanani, M., A. Platt-Higgins, P. S. Rudland, and F. C. Campbell. 2004. Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription. J. Biol. Chem. 279:20794–20806.
   PubMed Web of Science ®Google Scholar
• Espinosa, J. M., and B. M. Emerson. 2001. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell 8:57–69.
   PubMed Web of Science ®Google Scholar
• Giese, K., A. Amsterdam, and R. Grosschedl. 1991. DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. Genes Dev. 5:2567–2578.
   PubMed Web of Science ®Google Scholar
• Giese, K., J. Cox, and R. Grosscheldl. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69:185–196.
   PubMed Web of Science ®Google Scholar
• Göhler, T., M. Reimann, D. Cherny, K. Walter, G. Warnecke, E. Kim, and W. Deppert. 2002. Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain. J. Biol. Chem. 277:41192–41203.
   PubMedGoogle Scholar
• Grosschedl, R., K. Giese, and J. Pagel. 1994. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 10:94–100.
   PubMed Web of Science ®Google Scholar
• Gustavson, M. D., H. C. Crawford, B. Fingleton, and L. M. Matrisian. 2004. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Mol. Carcinog. 41:125–139.
   PubMedGoogle Scholar
• Hallikas, O., K. Palin, N. Sinjushina, R. Rautiainen, J. Partanen, E. Ukkonen, and J. Taipale. 2006. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 124:47–59.
   PubMed Web of Science ®Google Scholar
• He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512.
   PubMed Web of Science ®Google Scholar
• Hecht, A., and M. P. Stemmler. 2003. Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4. J. Biol. Chem. 278:3776–3785.
   PubMedGoogle Scholar
• Hovanes, K., T. W. Li, J. E. Munguia, T. Truong, T. Milovanovic, J. Lawrence Marsh, R. F. Holcombe, and M. L. Waterman. 2001. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet. 28:53–57.
   PubMed Web of Science ®Google Scholar
• Hovanes, K., T. W. H. Li, and M. L. Waterman. 2000. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res. 28:1994–2003.
   PubMed Web of Science ®Google Scholar
• Hurlstone, A., and H. Clevers. 2002. T-cell factors: turn-ons and turn-offs. EMBO J. 21:2303–2311.
   PubMedGoogle Scholar
• Jho, E.-H., T. Zhang, C. Domon, C.-K. Joo, J. N. Freund, and F. Costantini. 2002. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 22:1172–1183.
   PubMed Web of Science ®Google Scholar
• Kitayner, M., H. Rozenberg, N. Kessler, D. Rabinovich, L. Shaulov, T. E. Haran, and Z. Shakked. 2006. Structural basis of DNA recognition by p53 tetramers. Mol. Cell 22:741–753.
   PubMed Web of Science ®Google Scholar
• Love, J. J., X. Li, D. A. Case, K. Giese, R. Grosschedl, and P. E. Wright. 1995. Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376:791–795.
   PubMed Web of Science ®Google Scholar
• Love, J. J., X. Li, J. Chung, H. J. Dyson, and P. E. Wright. 2004. The LEF-1 high-mobility group domain undergoes a disorder-to-order transition upon formation of a complex with cognate DNA. Biochemistry 43:8725–8734.
   PubMedGoogle Scholar
• Maeda, T., R. M. Hobbs, T. Merghoub, I. Guernah, A. Zelent, C. Cordon-Cardo, J. Teruya-Feldstein, and P. P. Pandolfi. 2005. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433:278–285.
   PubMed Web of Science ®Google Scholar
• McKinney, K., M. Mattia, V. Gottifredi, and C. Prives. 2004. p53 linear diffusion along DNA requires its C terminus. Mol. Cell 16:413–424.
   PubMedGoogle Scholar
• McKinney, K., and C. Prives. 2002. Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein. Mol. Cell. Biol. 22:6797–6808.
   PubMed Web of Science ®Google Scholar
• Oshel, K. M., J. B. Knight, K. T. Cao, M. V. Thai, and A. L. Olson. 2000. Identification of a 30-base pair regulatory element and novel DNA binding protein that regulates the human GLUT4 promoter in transgenic mice. J. Biol. Chem. 275:23666–23673.
   PubMedGoogle Scholar
• Prieve, M. G., K. L. Guttridge, J. E. Munguia, and M. L. Waterman. 1998. Differential importin—a recognition and nuclear transport by nuclear localization signals within the high-mobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1. Mol. Cell. Biol. 18:4819–4832.
   PubMedGoogle Scholar
• Pukrop, T., D. Gradl, K. A. Henningfeld, W. Knochel, D. Wedlich, and M. Kuhl. 2001. Identification of two regulatory elements within the high mobility group box transcription factor XTCF-4. J. Biol. Chem. 276:8968–8978.
   PubMedGoogle Scholar
• Scaffidi, P., and M. E. Bianchi. 2001. Spatially precise DNA bending is an essential activity of the sox2 transcription factor. J. Biol. Chem. 276:47296–47302.
   PubMedGoogle Scholar
• Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96:5522–5527.
   PubMed Web of Science ®Google Scholar
• Skehan, P., R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, and M. R. Boyd. 1990. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82:1107–1112.
   PubMed Web of Science ®Google Scholar
• Tanaka, K., J. Shouguchi-Miyata, N. Miyamoto, and J. E. Ikeda. 2004. Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington's disease gene. J. Biol. Chem. 279:7275–7286.
   PubMed Web of Science ®Google Scholar
• Vadlamudi, U., H. M. Espinoza, M. Ganga, D. M. Martin, X. Liu, J. F. Engelhardt, and B. A. Amendt. 2005. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J. Cell Sci. 118:1129–1137.
   PubMed Web of Science ®Google Scholar
• van Beest, M., D. Dooijes, M. van De Wetering, S. Kjaerulff, A. Bonvin, O. Nielsen, and H. Clevers. 2000. Sequence-specific high mobility group box factors recognize 10-12-base pair minor groove motifs. J. Biol. Chem. 275:27266–27273.
   PubMed Web of Science ®Google Scholar
• Van de Wetering, M., J. Castrop, V. Korinek, and H. Clevers. 1996. Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties. Mol. Cell. Biol. 16:745–752.
   PubMedGoogle Scholar
• van de Wetering, M., R. Cavallo, D. Dooijes, M. van Beest, J. van Es, J. Loureiro, A. Ypma, D. Hursh, T. Jones, A. Bejsovec, M. Peifer, M. Mortin, and H. Clevers. 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88:789–799.
   PubMed Web of Science ®Google Scholar
• van de Wetering, M., E. Sancho, C. Verweij, W. de Lau, I. Oving, A. Hurlstone, K. van der Horn, E. Batlle, D. Coudreuse, A. P. Haramis, M. Tjon-Pon-Fong, P. Moerer, M. van den Born, G. Soete, S. Pals, M. Eilers, R. Medema, and H. Clevers. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111:241–250.
   PubMed Web of Science ®Google Scholar
• van Noort, M., and H. Clevers. 2002. TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev. Biol. 244:1–8.
   PubMed Web of Science ®Google Scholar
• Werner, M., J. Huth, A. Gronenborn, and G. Clore. 1995. Molecular basis of human 46X, Y sex reversal revealed from the three-dimensional solution structure of the human SRY-DNA complex. Cell 81:705–714.
   PubMed Web of Science ®Google Scholar
• Wright, W. E., M. Binder, and W. Funk. 1991. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell. Biol. 11:4104–4110.
   PubMed Web of Science ®Google Scholar
• Yochum, G. S., S. McWeeney, V. Rajaraman, R. Cleland, S. Peters, and R. H. Goodman. 2007. Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proc. Natl. Acad. Sci. USA 104:3324–3329.
   PubMedGoogle Scholar